Bigtincan (ASX:BTH) has successfully raised funds via an institutional placement
Bigtincan Holdings Limited (ASX:BTH) has successfully completed an institutional placement. The raising was completed alongside the recently announced acquisition of ClearSlide, a sales engagement technology platform leader with over 500 customers across three continents. Funds will also be used to support the acquisition integration, working capital and future growth of the company.
Bigtincan is a software company that has developed an AI-powered sales enablement automation platform aimed at achieving improved success of sales and customer satisfaction. The mobile platform solution features the industry’s premier user experience that empowers sales representatives to more effectively engage with customers and prospects and encourages team-wide adoption.
Oaklins’ team in Australia acted as joint lead manager and bookrunner to Bigtincan Holdings.
David Keane
Co-founder and CEO, Bigtincan Holdings Limited
Talk to the deal team
Related deals
Amcomri Group has completed an initial public offering
Amcomri Group plc has successfully completed an initial public offering (IPO) on the AIM Market of the London Stock Exchange, successfully raising US$15 million (£12 million) through a placing. The IPO will enable Amcomri to further its ‘Buy-Improve-Build’ strategy in the UK engineering sector.
Learn moreTekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more